Lung cancer is one of the leading causes of death among the people. Cigarette smoking is the major risk factor for the cause of lung cancer. Though it may occur in non-smokers…
Drug: Tarceva (Erlotinib Hydrochloride) to Treat NSCLC
Tarceva (Erlotinib Hydrochloride) is a non-chemotherapy drug for the treatment of lung cancer. It is used in the treatment of recurrent NSCLC. It is approved for patients with advanced-stage NSCLC whose cancer…
Drug: Cyramza (Ramucirumab) to Treat NSCLC
Lung Cancer Treatment Cyramza (Ramucirumab) is an approved drug for the treatment of non-small cell lung cancer (NSCLC). It was approved by US FDA as a single agent for treatment of patients…
Drug: Crizotinib for Lung Cancer
Crizotinib FDA Approved Among cancer-related deaths in the United States, lung cancer is the leading cause. FDA has approved the use of Xalkori (crizotinib) for treating patients with non-small cell lung cancer…
Drug: Ceritinib to Treat NSCLC
Ceritinib for Lung Cancer Treatment Ceritinib is a drug for the treatment of lung cancer. It is the generic for the trade chemotherapy drug Zykadia. The drug is a prescription medicine to…
Drug: Avastin (Bevacizumab) to Treat NSCLC
Avastin for Lung Cancer Avastin (Bevacizumab) is a cancer medicine that works to stop the growth and spread of cancer cells. It is used to treat certain types of cancers such as…
Drug: Atezolizumab to Treat NSCLC
Atezolizumab for Lung Cancer Treatment Lung cancer is a leading cause of cancer death at a global level. Atezolizumab, trade name Tecentriq, is indicated for patients with metastatic non-small cell lung cancer…
Drug: Alecensa (Alectinib) to Treat NSCLC
Alecensa (Alectinib) – FDA Approved Lung cancer is one of the leading causes of cancer deaths. Alecensa (alectinib) is an FDA approved drug for the treatment of non-small cell lung cancer (NSCLC)….